Loading...
Shineco, Inc.
TYHT•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$11.09
$-0.45(-3.90%)
Shineco, Inc. (TYHT) Financial Performance & Statements
Review Shineco, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1680.61%
↑ 1680.61%
Operating Income Growth
-94.87%
↓ 94.87%
Net Income Growth
-121.86%
↓ 121.86%
Operating Cash Flow Growth
27.09%
↑ 27.09%
Operating Margin
-143.53%
↓ 143.53%
Gross Margin
6.95%
↑ 6.95%
Net Profit Margin
-398.53%
↓ 398.53%
ROE
-140.76%
↓ 140.76%
ROIC
-37.97%
↓ 37.97%
Shineco, Inc. (TYHT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Shineco, Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $3.05M | $2.17M | $4.50M | $1.35M |
| Cost of Revenue | $2.93M | $1.88M | $4.22M | $2.50M |
| Gross Profit | $121460.00 | $291841.00 | $279228.00 | -$1.15M |
| Gross Profit Ratio | $0.04 | $0.13 | $0.06 | -$0.85 |
| R&D Expenses | $25697.00 | $13418.00 | $35615.00 | $31895.00 |
| SG&A Expenses | $2.73M | $2.67M | $5.47M | $2.04M |
| Operating Expenses | $2.76M | $2.68M | $5.51M | $2.07M |
| Total Costs & Expenses | $5.69M | $4.56M | $9.72M | $4.58M |
| Interest Income | -$146976.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $185524.00 | $408751.00 | $426190.00 | $418534.00 |
| Depreciation & Amortization | $1.36M | $1.38M | -$3.75M | $1.34M |
| EBITDA | -$990275.00 | -$1.05M | -$18.74M | -$1.86M |
| EBITDA Ratio | -$0.32 | -$0.48 | -$4.17 | -$1.39 |
| Operating Income | -$2.64M | -$2.39M | -$5.22M | -$3.23M |
| Operating Income Ratio | -$0.87 | -$1.10 | -$1.16 | -$2.39 |
| Other Income/Expenses (Net) | $106437.00 | -$460686.00 | -$15.35M | -$644748.00 |
| Income Before Tax | -$2.53M | -$2.85M | -$20.57M | -$3.87M |
| Income Before Tax Ratio | -$0.83 | -$1.31 | -$4.57 | -$2.87 |
| Income Tax Expense | -$907818.00 | -$292951.00 | -$298863.00 | $497889.00 |
| Net Income | -$1.62M | -$2.02M | -$20.14M | -$3.35M |
| Net Income Ratio | -$0.53 | -$0.93 | -$4.48 | -$2.48 |
| EPS | -$0.90 | -$2.34 | -$14.77 | -$2.46 |
| Diluted EPS | -$0.90 | -$2.34 | -$14.77 | -$2.46 |
| Weighted Avg Shares Outstanding | $1.80M | $862839.00 | $1.36M | $1.36M |
| Weighted Avg Shares Outstanding (Diluted) | $1.80M | $862839.00 | $1.36M | $1.36M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan